Literature DB >> 762498

C5b-9 dimer: isolation from complement lysed cells and ultrastructural identification with complement-dependent membrane lesions.

G Biesecker, E R Podack, C A Halverson, H J Müller-Eberhard.   

Abstract

The membrane attack complex (MAC) of complement was extracted from the membranes of cells lysed by human complement and its properties were compared with those of the fluid phase complex SC5b-9. Upon sodium dodecyl sulfate polyacrylamide gel electrophoresis and immunochemical analysis, the two isolated complexes had identical subunit compositions, except that the MAC lacked the S-protein. The sedimentation coefficient and molecular weight of the extracted and isolated MAC were, respectively, 33.5 S and 1.7 x 10(6) daltons, compared to 23 S and 1.0 x 10(6) dalton for SC5b-9. Because the molecular weight of the MAC is approximately two times greater than that of C5b-0 (800,000 daltons), the MAC is considered the dimer of C5b-9. Under specified conditions, the 33.5 S dimer could be converted to the 23 S monomer without dissociation of subunits. The MAC had the electron microscopic appearance and dimensions that are characteristic for the complement produced ultrastructural membrane lesions. SC5b-9 had a different ultrastructure that is dissimilar to the morphology of the lesions. The isolated MAC could be reincorporated into phospholipid bilayers and assumed on the surface of the resultant lipid vesicles the orientation and appearance of typical complement lesions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 762498      PMCID: PMC2184804          DOI: 10.1084/jem.149.2.448

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  21 in total

1.  Single bilayer vesicles prepared without sonication. Physico-chemical properties.

Authors:  J Brunner; P Skrabal; H Hauser
Journal:  Biochim Biophys Acta       Date:  1976-12-02

2.  LESIONS IN ERYTHROCYTE MEMBRANES CAUSED BY IMMUNE HAEMOLYSIS.

Authors:  T BORSOS; R R DOURMASHKIN; J H HUMPHREY
Journal:  Nature       Date:  1964-04-18       Impact factor: 49.962

3.  Phosphorus assay in column chromatography.

Authors:  G R BARTLETT
Journal:  J Biol Chem       Date:  1959-03       Impact factor: 5.157

4.  The structural events associated with the attachment of complement components to cell membranes in reactive lysis.

Authors:  R R Dourmashkin
Journal:  Immunology       Date:  1978-08       Impact factor: 7.397

5.  A method of trace iodination of proteins for immunologic studies.

Authors:  P J McConahey; F J Dixon
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Binding of desoxycholate, phosphatidylcholine vesicles, lipoprotein and of the S-protein to complexes of terminal complement components.

Authors:  E R Podack; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-09       Impact factor: 5.422

7.  Complement lysis: the ultrastructure and orientation of the C5b-9 complex on target sheep erythrocyte membranes.

Authors:  J Tranum-Jensen; S Bhakdi; B Bhakdi-Lehnen; O J Bjerrum; V Speth
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

8.  The C5b-6 complex: formation, isolation, and inhibition of its activity by lipoprotein and the S-protein of human serum.

Authors:  E R Podack; W P Kolb; H J Müller-Eberhard
Journal:  J Immunol       Date:  1978-06       Impact factor: 5.422

9.  Complement-induced ultrastructural membrane lesions: requirement for terminal components.

Authors:  C H Packman; S I Rosenfeld; R I Weed; J P Leddy
Journal:  J Immunol       Date:  1976-11       Impact factor: 5.422

10.  The membrane attack mechanism of complement. Verification of a stable C5-9 complex in free solution.

Authors:  W P Kolb; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1973-08-01       Impact factor: 14.307

View more
  27 in total

1.  Blood dendritic cells carry terminal complement complexes on their cell surface as detected by newly developed neoepitope-specific monoclonal antibodies.

Authors:  R Würzner; H Xu; A Franzke; M Schulze; J H Peters; O Götze
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

2.  Evidence for a two-domain structure of the terminal membrane C5b-9 complex of human complement.

Authors:  S Bhakdi; J Tranum-Jensen
Journal:  Proc Natl Acad Sci U S A       Date:  1979-11       Impact factor: 11.205

3.  Are complement lysis and lymphocytotoxicity analogous?

Authors:  P J Lachmann
Journal:  Nature       Date:  1983 Oct 6-12       Impact factor: 49.962

4.  Complement-mediated lysis of pigeon erythrocyte ghosts analysed by flow cytometry. Evidence for the involvement of a 'threshold' phenomenon.

Authors:  S W Edwards; B P Morgan; T G Hoy; J P Luzio; A K Campbell
Journal:  Biochem J       Date:  1983-10-15       Impact factor: 3.857

Review 5.  The membrane attack complex.

Authors:  H J Müller-Eberhard
Journal:  Springer Semin Immunopathol       Date:  1984

Review 6.  Is the membrane attack complex of complement an enzyme?

Authors:  M D Boyle
Journal:  Mol Cell Biochem       Date:  1984       Impact factor: 3.396

7.  Transmembrane channel formation by complement: functional analysis of the number of C5b6, C7, C8, and C9 molecules required for a single channel.

Authors:  L E Ramm; M B Whitlow; M M Mayer
Journal:  Proc Natl Acad Sci U S A       Date:  1982-08       Impact factor: 11.205

8.  Polymerization of the ninth component of complement (C9): formation of poly(C9) with a tubular ultrastructure resembling the membrane attack complex of complement.

Authors:  E R Podack; J Tschopp
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

9.  Studies of progressive glomerular sclerosis in the rat.

Authors:  S Adler; L J Striker; G E Striker; D T Perkinson; J Hibbert; W G Couser
Journal:  Am J Pathol       Date:  1986-06       Impact factor: 4.307

10.  Inhibition of the complement membrane attack complex by Schistosoma mansoni paramyosin.

Authors:  Jiusheng Deng; Daniel Gold; Philip T LoVerde; Zvi Fishelson
Journal:  Infect Immun       Date:  2003-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.